FDA Announces Updated Guidance on 510K Processes On December 20, 2023, the U.S. Food and Drug Administration (FDA) announced new draft guidance on the 510(k) Third Party Review (3P510k) Program and the Third Party Emergency Use Authorization (EUA) Review (3PEUA). The draft guidance contains detailed steps regarding what is expected for submissions in both the...